Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

News

FDA has granted approval to the Cordis Endovascular division of Cordis Corp. to market its PRECISE RX Nitinol Self ...

Home February 19, 2007
Home
Feature | Mark Paquin

Author’s Note: For this inaugural article I begin with an insider’s look on the “health” of drug-eluting stents ...

Home February 06, 2007
Home
News

Feb. 7, 2007 — Abbott has announced its plan to launch the world's first drug-eluting stent clinical trial solely in ...

Home February 06, 2007
Home
Technology

The first interwoven nitinol self-expanding stent available in the U.S. for palliative treatment of malignant strictures ...

Home February 06, 2007
Home
News

Feb. 6, 2007 — The Centers for Medicare and Medicaid Services (CMS) has released new proposed policy in which coverage ...

Home February 05, 2007
Home
News

Feb. 1, 2007 — Cook Medical released nine-month data this week for its PTX Paclitaxel-Eluting Stent (DES) trial, which ...

Home January 31, 2007
Home
News

Feb. 1, 2007 — Stockholders of Conor Medsystems, Inc. have approved the merger agreement between Conor and Johnson & ...

Home January 31, 2007
Home
News

Jan. 29, 2007 — Abbott Vascular surpassed Cordis for the first time in December 2006 as the market leader in peripheral ...

Home January 28, 2007
Home
News

Jan. 25, 2007 — ev3 Inc. has announced FDA approval of the PROTÉGÉ RX Carotid Stent, which, when used in conjunction ...

Home January 24, 2007
Home
News

Jan. 23, 2007 — Carotid stent maker ev3 will sponsor an evening symposium at the International Symposium of Endovascular ...

Home January 22, 2007
Home
News

Jan. 19, 2007 — The second generation Coating Durability Tester (CDT2) by Dynatek will be exhibited at the Medical ...

Home January 18, 2007
Home
News

Jan. 15, 2007 — Boston Scientific Corp. has announced the international launch and first implantation of the PROMUS ...

Home January 14, 2007
Home
News

Jan. 11, 2007 — The Society for Cardiovascular Angiography and Interventions (SCAI) today released a clinical alert ...

Home January 10, 2007
Home
News

Jan. 5, 2007 — A French court has ruled that Abbott Laboratories’ Xience V drug-eluting coronary stents infringe patents ...

Home January 04, 2007
Home
News

Implant Sciences Corp. a wholly-owned German subsidiary of CorNova, Inc., has received CE Mark marketing approval for ...

Home January 01, 2007
Home
Subscribe Now